Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02704559

Enrollment

Registered

2016-03-10

Start date

2015-12-31

Completion date

2016-02-29

Last updated

2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

A randomized, open-label, oral dose, crossover study to explore drug-drug interactions between DWC20155 and DWC20156 in healthy subjects.

Interventions

DRUGDWC20155

DRUGDWC20156

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

19 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Accepts healthy volunteers.

Exclusion criteria

* Who has allergy to investigational product

Design outcomes

Primary

Measure	Time frame
Peak Plasma Concentration (Cmax)	0~24hr
Area under the plasma concentration versus time curve (AUC)	0~24h

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026